USP DI(r) Drug Information for the Health Care Professional has been succeeded by Thomson Healthcare's enhanced DrugPoints(r). Like USP DI, DrugPoints contains concise drug information designed to assist clinicians in making informed, evidence-based decisions about the proper care and treatment of their patients. The
two products will provide comparable drug information, plus DrugPoints will feature Black Box Warnings, images, and a new toxicology section not currently available in USP DI. Additionally, DrugPoints includes expanded evidence-based medicine ratings of drug indications.